Indication

Glycogen storage disease type Ia

Glycogen storage disease type Ia is an inherited autosomal recessive metabolic disorder caused by a deficiency of the catalytic subunit of glucose-6-phosphatase. Read more about Glycogen storage disease type Ia

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Glycogen storage disease type Ia therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Glycogen storage disease type Ia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Glycogen storage disease type Ia.

Glycogen storage disease type Ia is an inherited autosomal recessive metabolic disorder caused by a deficiency of the catalytic subunit of glucose-6-phosphatase.

This enzymatic defect impairs both glycogenolysis and gluconeogenesis, primarily affecting the liver and kidneys through excessive intracellular accumulation of glycogen and fat.

Typically presenting in early infancy with fasting intolerance, hallmark clinical features include severe fasting hypoglycemia, hepatomegaly, lactic acidosis, hypertriglyceridemia, and hyperuricemia.

Over time, chronic disease may lead to complications such as growth impairment, hepatic adenomas, osteoporosis, and progressive renal dysfunction.

Personalize your experience

Follow Glycogen storage disease type Ia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it